← Evidence map

ArticleKidney international reports2025

Response to the Letter to the Editor Entitled "Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes".

Neera K Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Response to the Letter to the Editor Entitled "Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes". | OpenQuestion